DK1021456T3 - Makrocykliske derivater af erythromysin A og B med 13-leddet ring - Google Patents

Makrocykliske derivater af erythromysin A og B med 13-leddet ring

Info

Publication number
DK1021456T3
DK1021456T3 DK97922483T DK97922483T DK1021456T3 DK 1021456 T3 DK1021456 T3 DK 1021456T3 DK 97922483 T DK97922483 T DK 97922483T DK 97922483 T DK97922483 T DK 97922483T DK 1021456 T3 DK1021456 T3 DK 1021456T3
Authority
DK
Denmark
Prior art keywords
membered ring
erythromysin
macrocyclic derivatives
hypermotilinemia
pharmaceutical compositions
Prior art date
Application number
DK97922483T
Other languages
English (en)
Inventor
Paul A Lartey
Cynthia Brunell Curty
Ramin Faghih
Hugh Nerby Nellans
Albert Christian Petersen
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1021456T3 publication Critical patent/DK1021456T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK97922483T 1996-06-18 1997-04-25 Makrocykliske derivater af erythromysin A og B med 13-leddet ring DK1021456T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/668,050 US5712253A (en) 1996-06-18 1996-06-18 Macrocyclic 13-membered ring derivatives of erythromycins A and B
PCT/US1997/007015 WO1997048713A1 (en) 1996-06-18 1997-04-25 Macrocyclic 13-membered ring derivatives of erythromycins a and b

Publications (1)

Publication Number Publication Date
DK1021456T3 true DK1021456T3 (da) 2003-08-18

Family

ID=24680797

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97922483T DK1021456T3 (da) 1996-06-18 1997-04-25 Makrocykliske derivater af erythromysin A og B med 13-leddet ring

Country Status (10)

Country Link
US (1) US5712253A (da)
EP (1) EP1021456B1 (da)
JP (1) JP2000512653A (da)
AT (1) ATE236185T1 (da)
CA (1) CA2257361A1 (da)
DE (1) DE69720551T2 (da)
DK (1) DK1021456T3 (da)
ES (1) ES2196331T3 (da)
PT (1) PT1021456E (da)
WO (1) WO1997048713A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023629A1 (fr) * 1996-11-26 1998-06-04 Chugai Seiyaku Kabushiki Kaisha Composes de macrolides comportant une chaine a 13 elements, medicament les contenant et leur procede de preparation
TW460478B (en) 1997-08-15 2001-10-21 Chugai Pharmaceutical Co Ltd Phenethylamine derivatives
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
US6165985A (en) * 1998-02-13 2000-12-26 Solvay Pharmaceuticals Gmbh 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them
DE19805822B4 (de) * 1998-02-13 2009-02-05 Solvay Pharmaceuticals Gmbh 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CA2330251A1 (en) * 1998-06-12 1999-12-16 Merck & Co., Inc. Cloning and identification of the motilin receptor
TW509699B (en) 1998-09-24 2002-11-11 Chugau Pharmaceutical Co Ltd Ethylamine derivatives
US7553969B1 (en) 1999-01-28 2009-06-30 Chugai Seiyaku Kabushiki Kaisha Substituted phenethylamine derivatives
US7179886B1 (en) 1999-06-08 2007-02-20 Merck & Co., Inc. Cloning and identification of the motilin receptor
EP1255763A2 (en) 2000-02-18 2002-11-13 Kosan Biosciences, Inc. Motilide compounds
WO2002057791A2 (en) * 2000-11-29 2002-07-25 Lifespan Biosciences, Inc. Diagnostic and therapeutic compositions and methods related to grp 38
US20030186336A1 (en) * 2001-11-29 2003-10-02 Burmer Glenna C. Diagnostic and therapeutic compositions and methods related to GPCR 38, a G protein-coupled receptor (GPCR)
SI1532131T1 (sl) * 2002-08-29 2009-04-30 Pfizer Motilidne spojine
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US7521420B2 (en) 2003-06-18 2009-04-21 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor
US7550431B2 (en) * 2003-07-31 2009-06-23 Tranzyme Pharma Inc. Spatially-defined macrocycles incorporating peptide bond surrogates
ES2357235T7 (es) 2003-07-31 2013-02-14 Tranzyme Pharma Inc. Compuestos macrocíclicos definidos espacialmente útiles para el descubrimiento de fármacos
US7407941B2 (en) * 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
US20050113319A1 (en) * 2003-08-26 2005-05-26 Christopher Carreras 11-Deoxy-6,9-ether erythromycin compounds
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US20080249034A1 (en) * 2005-03-21 2008-10-09 Zambon S.P.A. Use of Macrolides for Treating Intestinal Inflammation
EP1861490A4 (en) * 2005-03-23 2010-11-17 Univ St Louis USE OF ARRAYS TO MODULATE NUTRIENT CAPTURE FUNCTIONS BY THE GASTROINTESTINAL MICROBIOTE
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
CA2632779A1 (en) * 2005-12-08 2007-06-14 Pfizer Inc. Method for demethylating the 3'-dimethylamino group of erythromycin compounds
US8088733B2 (en) 2006-07-06 2012-01-03 Tranzyme Pharma Inc. Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders
JP5684474B2 (ja) 2006-09-11 2015-03-11 オセラ セラピューティクス， インコーポレイテッド 胃腸の運動障害疾患の治療のためのモチリン受容体の大環状アンタゴニスト
EP2104680B1 (en) 2006-12-05 2013-01-09 Bristol-Myers Squibb Company Motilide polymorphs
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878192A (en) * 1972-06-05 1975-04-15 Blasina Lab Chim Farm Sweet and palatable water soluble derivatives of erythromycin
JPS6187625A (ja) * 1984-10-05 1986-05-06 Satoshi Omura 消化管収縮運動促進剤
EP0215355B1 (en) * 1985-08-31 1994-04-06 Kitasato Kenkyusho Erythromycin derivative and process for preparing the same
US5008249A (en) * 1985-08-31 1991-04-16 Kitasato Kenkyusho Therapeutic method of stimulating digestive tract contractile motion in mammals
US4681872A (en) * 1985-11-12 1987-07-21 Abbott Laboratories Erythromycin A 11,12-carbonate and method of use
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
MY103197A (en) * 1987-02-20 1993-05-29 Kitasato Inst A growth promoting composition and production thereof
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders

Also Published As

Publication number Publication date
EP1021456A1 (en) 2000-07-26
DE69720551T2 (de) 2004-02-26
DE69720551D1 (de) 2003-05-08
ES2196331T3 (es) 2003-12-16
EP1021456B1 (en) 2003-04-02
PT1021456E (pt) 2003-08-29
WO1997048713A1 (en) 1997-12-24
US5712253A (en) 1998-01-27
JP2000512653A (ja) 2000-09-26
ATE236185T1 (de) 2003-04-15
CA2257361A1 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
DK1021456T3 (da) Makrocykliske derivater af erythromysin A og B med 13-leddet ring
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
DK0948527T3 (da) Cylosporinderivater, fremstilling af disse og farmaceutiske præparater indeholdende disse
NO996108L (no) 9-oksinerytromycinderivater
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
TR200103395T2 (tr) 13-metil eritromisin türevleri.
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
GB9322643D0 (en) Lactam derivatives
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
ATE259823T1 (de) Tricyclische erythromycinderivate
ATE164848T1 (de) 4''-deoxyerythromycinderivate
DK0665834T3 (da) Quinolon- og acridinonderivater til behandling af urininkontinens
ATE211729T1 (de) Therapeutisch wirksame verbindungen
CA2286511A1 (en) Novel macrolide derivatives
DK0625516T3 (da) Benzensulfonamidderivater til behandling af blæreustabilitet
AP9801377A0 (en) Tricyclic erythromycin derivatives.
DK0628042T3 (da) Serotoninerge ergolinderivater
WO2001005386A3 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
DE69923117D1 (de) Verwendung von Homocysteinderivaten zur Behandlung von bakteriellen Infektionen
GR3020922T3 (en) Amide derivatives of 1-amino-octahydropyrido[2,1-c][1,4]oxazine, processes for their preparation and pharmaceutical compositions containing them
MX9704299A (es) Derivados de bencimidazol.